Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study.

De Marchis GM, Katan M, Weck A, Fluri F, Foerch C, Findling O, Schuetz P, Buhl D, El-Koussy M, Gensicke H, Seiler M, Morgenthaler N, Mattle HP, Mueller B, Christ-Crain M, Arnold M.

Neurology. 2013 Apr 2;80(14):1278-86. doi: 10.1212/WNL.0b013e3182887944. Epub 2013 Mar 6.

PMID:
23468541
2.

Copeptin: a novel, independent prognostic marker in patients with ischemic stroke.

Katan M, Fluri F, Morgenthaler NG, Schuetz P, Zweifel C, Bingisser R, Müller K, Meckel S, Gass A, Kappos L, Steck AJ, Engelter ST, Müller B, Christ-Crain M.

Ann Neurol. 2009 Dec;66(6):799-808. doi: 10.1002/ana.21783. Erratum in: Ann Neurol. 2010 Feb;67(2):277-81.

PMID:
20035506
3.

Plasma copeptin and long-term outcomes in acute ischemic stroke.

Zhang JL, Yin CH, Zhang Y, Zhao LB, Fu HJ, Feng JC.

Acta Neurol Scand. 2013 Dec;128(6):372-80. doi: 10.1111/ane.12132. Epub 2013 Apr 25.

PMID:
23614762
4.

Prognostic value of copeptin: one-year outcome in patients with acute stroke.

Urwyler SA, Schuetz P, Fluri F, Morgenthaler NG, Zweifel C, Bergmann A, Bingisser R, Kappos L, Steck A, Engelter S, Müller B, Christ-Crain M, Katan M.

Stroke. 2010 Jul;41(7):1564-7. doi: 10.1161/STROKEAHA.110.584649. Epub 2010 May 27.

5.

Plasma levels of copeptin predict 1-year mortality in patients with acute ischemic stroke.

Wang CW, Wang JL, Zhang Y, Li Q, Guo SX, Ji SB.

Neuroreport. 2014 Dec 17;25(18):1447-52. doi: 10.1097/WNR.0000000000000290.

PMID:
25383462
6.

Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.

De Marchis GM, Weck A, Audebert H, Benik S, Foerch C, Buhl D, Schuetz P, Jung S, Seiler M, Morgenthaler NG, Mattle HP, Mueller B, Christ-Crain M, Arnold M, Katan M.

Stroke. 2014 Oct;45(10):2918-23. doi: 10.1161/STROKEAHA.114.005584. Epub 2014 Aug 28.

7.

ASTRAL score predicts 5-year dependence and mortality in acute ischemic stroke.

Papavasileiou V, Milionis H, Michel P, Makaritsis K, Vemmou A, Koroboki E, Manios E, Vemmos K, Ntaios G.

Stroke. 2013 Jun;44(6):1616-20. doi: 10.1161/STROKEAHA.113.001047. Epub 2013 Apr 4.

8.

Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk study.

De Marchis GM, Katan M, Weck A, Brekenfeld C, Mattle HP, Buhl D, Müller B, Christ-Crain M, Arnold M.

Int J Stroke. 2013 Apr;8(3):214-8. doi: 10.1111/j.1747-4949.2011.00762.x. Epub 2012 Feb 15.

PMID:
22336226
9.

Copeptin is associated with mortality in patients with traumatic brain injury.

Dong XQ, Huang M, Yang SB, Yu WH, Zhang ZY.

J Trauma. 2011 Nov;71(5):1194-8. doi: 10.1097/TA.0b013e31821283f2.

PMID:
21502880
10.

C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.

Khan SQ, Dhillon OS, O'Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL.

Circulation. 2007 Apr 24;115(16):2103-10. Epub 2007 Apr 9.

11.

Plasma copeptin levels in Chinese patients with acute ischemic stroke: a preliminary study.

Dong X, Tao DB, Wang YX, Cao H, Xu YS, Wang QY.

Neurol Sci. 2013 Sep;34(9):1591-5. doi: 10.1007/s10072-013-1291-2. Epub 2013 Jan 25.

PMID:
23354601
12.

Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage.

Zhu XD, Chen JS, Zhou F, Liu QC, Chen G, Zhang JM.

Crit Care. 2011;15(6):R288. doi: 10.1186/cc10575. Epub 2011 Nov 29.

13.

Prognostic value of copeptin: one-year outcome in patients with traumatic brain injury.

Yu GF, Huang Q, Dai WM, Jie YQ, Fan XF, Wu A, Lv Y, Li YP, Yan XJ.

Peptides. 2012 Jan;33(1):164-9. doi: 10.1016/j.peptides.2011.11.017. Epub 2011 Nov 26.

PMID:
22138140
14.

Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage.

Zweifel C, Katan M, Schuetz P, Siegemund M, Morgenthaler NG, Merlo A, Mueller B, Christ-Crain M.

BMC Neurol. 2010 May 26;10:34. doi: 10.1186/1471-2377-10-34.

15.

Copeptin is associated with one-year mortality and functional outcome in patients with acute spontaneous basal ganglia hemorrhage.

Zhang X, Lu XM, Huang LF, Ye H.

Peptides. 2012 Feb;33(2):336-41. doi: 10.1016/j.peptides.2012.01.011. Epub 2012 Jan 24.

PMID:
22286033
16.

Plasma copeptin, a possible prognostic marker in cirrhosis.

Moreno JP, Grandclement E, Monnet E, Clerc B, Agin A, Cervoni JP, Richou C, Vanlemmens C, Dritsas S, Dumoulin G, Di Martino V, Thevenot T.

Liver Int. 2013 Jul;33(6):843-51. doi: 10.1111/liv.12175. Epub 2013 Apr 7.

PMID:
23560938
17.

C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study.

Narayan H, Dhillon OS, Quinn PA, Struck J, Squire IB, Davies JE, Ng LL.

Clin Sci (Lond). 2011 Jul;121(2):79-89. doi: 10.1042/CS20100564.

PMID:
21309746
18.

Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke.

Katan M, Fluri F, Schuetz P, Morgenthaler NG, Zweifel C, Bingisser R, Kappos L, Steck A, Engelter ST, Müller B, Christ-Crain M.

J Am Coll Cardiol. 2010 Sep 21;56(13):1045-53. doi: 10.1016/j.jacc.2010.02.071.

19.

Copeptin and Long-Term Risk of Recurrent Vascular Events After Transient Ischemic Attack and Ischemic Stroke: Population-Based Study.

Greisenegger S, Segal HC, Burgess AI, Poole DL, Mehta Z, Rothwell PM.

Stroke. 2015 Nov;46(11):3117-23. doi: 10.1161/STROKEAHA.115.011021. Epub 2015 Oct 8.

PMID:
26451023
20.

Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure.

Tentzeris I, Jarai R, Farhan S, Perkmann T, Schwarz MA, Jakl G, Wojta J, Huber K.

Eur J Heart Fail. 2011 Jul;13(7):726-33. doi: 10.1093/eurjhf/hfr049. Epub 2011 May 26.

Items per page

Supplemental Content

Write to the Help Desk